China steps up Covid-19 vaccination, considers differentiated visa policies

China steps up Covid-19 vaccination, considers differentiated visa policies
China steps up Covid-19 vaccination, considers differentiated visa policies

Hello and welcome to the details of China steps up Covid-19 vaccination, considers differentiated visa policies and now with the details

Nevin Al Sukari - Sana'a - People fill forms before receiving a dose of a coronavirus disease (Covid-19) vaccine at a vaccination site in Shanghai January 19, 2021. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.

BEIJING, March 21 — China has accelerated its vaccinations against Covid-19, administering 10 million doses in around a week, and is considering varied visa policies based on vaccination and virus conditions in different countries, officials said today.

The country had administered 74.96 million vaccine doses as of yesterday, health commission spokesman Mi Feng told a news briefing. That is up from 64.98 million as of March 14.

China aims to vaccinate 40 per cent of its 1.4 billion people by the middle of the year, according to state media and a top health adviser. China was among the first countries to begin administering vaccines last year and has been exporting millions of doses, but its vaccination rate has fallen behind those of such countries as Israel and the United States.

More than 70 million doses of Sinovac Biotech’s shot have been administered globally, a company spokesman told the news conference, without specifying how many of those had been administered in China.

Beijing is considering differentiated policies for visa issuance, flights and controls on the numbers of people arriving in China based on vaccination progress and the Covid-19 situations in different countries.

“We do not exempt vaccinated people from testing and isolation measures for the time being,” said Feng Zijian, vice director of Chinese Centre for Disease Control and Prevention (China CDC).

But he said China will pay attention to international progress in developing “vaccine passports” and could adjust virus curbing measures after the domestic population reaches a high level of immunisation.

China’s full-year vaccine production can fully meet the needs of entire country, said Ministry of Industry and Information Technology official Mao Junfeng.

He said the supply of materials for vaccine production, including glass vials and syringes, is “relatively stable”.

Countries with high proportions of elderly people should be prioritised for vaccination, said Wu Zunyou, chief epidemiologist at China CDC.

If all countries push forward with their vaccination programs at the same pace, it is possible that each country might reach just 10 per cent or 30 per cent immunity, not enough to protect the population, Wu explained at the China Development Forum in Beijing on Saturday evening.

“We need to reach 70 per cent-80 per cent in one country as soon as possible, then a second country, then a third country,” Wu said.

China has approved four locally developed vaccines for general public use from Sinovac, CanSino Biologics and two units of China National Pharmaceutical Group (Sinopharm).

A fifth vaccine developed by the Institute of Microbiology of Chinese Academy of Sciences was approved for emergency use last week. — Reuters

These were the details of the news China steps up Covid-19 vaccination, considers differentiated visa policies for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Five dead in Belgium school collapse
NEXT Alpha, Beta, Gamma, Delta — WHO uses Greek alphabet to name COVID-19 variants